Journal
Blood Advances
Publication Date
2020
Volume
4
Issue
22
First Page
5825
Last Page
5835
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2020003314
Rights and Permissions
Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklos Egyed, Claire N. Harrison, Abdulraheem Yacoub, Alessandro Vannucchi, Adam J. Mead, Jean-Jacques Kiladjian, Jennifer O’Sullivan, Valentin García-Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah A. Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman-Torres, Sri Devineni, Adam R. Craig, John O. Mascarenhas; Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis. Blood Adv 2020; 4 (22): 5825–5835. doi: https://doi.org/10.1182/bloodadvances.2020003314
Recommended Citation
Gerds, Aaron T.; Oh, Stephen T.; and al., et, "Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis." Blood Advances. 4, 22. 5825 - 5835. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9849
